Back

Questions and answers / Panel discussion

31 August 2019 (16:40 - 16:45)
Organised by:
Congress Presentation Part of: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS) ESC Premium Access ESC Congress 2019

4 More presentations in this session

Presentation thumbnail
Clinical implications for patients at persistent ASCVD risk
Doctor J. Saseen (Aurora, US)
Slides Video
Presentation thumbnail
Clinical trial updates
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
The future of lipid management: new therapies for LDL-C lowering
Doctor H. Bays (Louisville, US)
Slides Video
Presentation thumbnail
Post-activity quiz and discussion
Doctor P. MORRIS (Charleston, US)
Slides Video

Access the full session

Session thumbnail
Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

The Event

Event poster

ESC Congress 2019

31 August 2019 16:40 CET
You may be interested in
thumbnail
Congress Presentation
EAS Consensus on Lp(a) 2022- What to measure, in whom to measure, how to interpret and what to do - Q&A .
29 August 2022
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
29 August 2025
thumbnail
Congress Presentation
Targeting lipids above and beyond statins: key new players - discussion
1 September 2024
thumbnail
Congress Presentation
Charting the future: panel discussion and Q&A
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources